The true scale of undiagnosed cases is based on BBC analysis of statistics submitted to the Infected Blood Inquiry by an ...

A new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients ...

CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-in-human study expected to start in first half of 2024 - - ...

Antiviral treatment with intravesical interferon provides better pain reduction in women with interstitial cystitis over 6 months compared with intravesical hyaluronic acid. Women with ...

In a recent study published in JAMA Network Open, researchers compared the performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

Considering taking a vitamin or supplement to treat Interferon-Related+Retinopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of Interferon-Related+Retinopathy.

Company announces positive initial Phase 1a dose escalation data for monotherapy CX-904 (EGFRxCD3 T-cell engager) in solid tumors -- First dose ...

Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Researchers have revealed the regulatory mechanism of a specific protein, TRBP, that plays a key role in balancing the immune response triggered by viral infections in mammal cells. These findings ...

A new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls. The study, which showed that highly ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...